Gattefossé

Compritol® 888 ATO: one excipient benefits all, from formulator to end-user Compritol® 888 ATO With a drug release governed by...

Abstract The excipient, Capryol® 90, comprises 90 % monoesters of propylene glycol monocaprylate (C8). With a low hydrophilic lipophilic balance...

Abstract Cancer remains to be one of the most life-threatening diseases with high rates of mortality and morbidity. The major...

Abstract Lipid-based formulations (LBFs) play a crucial role in enhancing the oral bioavailability of poorly water-soluble drugs by leveraging lipid...

Abstract Background: Centaurium erythraea Rafn. (C. erythraea) is a medicinal plant traditionally used in European folk medicine for the treatment of...

The new webinar by our partner Gattefossé: This webinar will explore how Self-Emulsifying Drug Delivery Systems (SEDDS) and other lipid-based...

Abstract The liquid and solid formulations of self-nano-emulsifying drug delivery systems (SNEDDS) have garnered significant attention in the pharmaceutical field...

Abstract For any drug to be therapeutically efficacious it must enter the systemic circulation and in order to do so,...

Abstract Nose to brain (N2B) delivery offers a potential means of bypassing challenges associated with drug delivery across the blood...

Abstract Hybrid lipid nanocapsules (hLNCs) represent a promising platform for mRNA delivery with the added benefit of ambient-temperature stabilization. Conventional...